ClinicalTrials.gg
RecruitingNCT07484828VentilO CUUpdated Nov 5, 2026

Evaluation of Acid-base Disorders and Ventilation Settings in Cardiogenic Shock and Post-cardiac Arrest Patients: Comparison With VentilO Algorithm

An observational study in Cardiac Arrest (CA), Cardiogenic Shock and Mechanical Ventilation, sponsored by Laval University. Recruiting at 1 site in Canada. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by Laval University · Observational

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.
Updated Nov 5, 2026Now RecruitingSite recruiting status changed+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
100
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 65 studies in Heart Arrest with a site in Canada — 10 open to participants now, 13 under way, 1 of them phase 3. Heart Arrest · Canada.

Planned enrollment
16th of 19
100 · median 793
Started
2026
with 2 others
Observational
19 of 65
3 open now
Primary completion
2027-06
later than 5 of 12 live
Registered
62nd of 65
by date

Among the 65 studies in Heart Arrest with a site in Canada, this one is the 16th largest by planned enrollment of the 19 observational ones that give a count, is one of 3 that started in 2026, is one of 19 observational ones, reaches primary completion later than 5 of the 12 other live ones, and was the 62nd registered.

Heart Arrest

927 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.

Browse Heart Arrest studies →

Open to participants now

10 of the 65 studies in Heart Arrest with a site in Canada are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 157 Heart Arrest studies recruiting now, 109 (69%) set no upper age limit and 28 (18%) stop at 75 or younger; 30 take children under 18; 18 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 65 studies in Heart Arrest with a site in Canada, or all of them as a file.
02

Study summary

This study aims to better understand how mechanical ventilation settings affect patients admitted to the coronary care unit after cardiac arrest or with cardiogenic shock. These patients often require mechanical ventilation, but current guidelines provide limited evidence on the best approach. Improper ventilation settings can lead to acid-base imbalances, such as respiratory acidosis or alkalosis, which may worsen patient outcomes.

The retrospective analysis will include 100 adult patients (50 post-cardiac arrest and 50 with cardiogenic shock) who were mechanically ventilated upon admission. The study has two main objectives:

Determine how often acid-base disorders occur in these patients and describe their characteristics.

Compare the initial ventilator settings chosen by clinicians with those suggested by VentilO, a decision-support algorithm.

The investigators will evaluate the potential effect of the VentilO recommendations on the first arterial (or capillary) blood gases compared to the real settings.

This information will help refine the algorithm and guide future research on improving ventilation strategies for critically ill cardiac patients.

Participation does not involve any intervention, as the study uses existing medical records.

03

Conditions studied

  • Cardiac Arrest (CA)
  • Cardiogenic Shock
  • Mechanical Ventilation
  • Acid Base Disorder
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

post cardiac arrest or cardiogenic shock

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult (Age >=18 years old)
  • Under mechanical ventilation with endotracheal tube for :

post cardiac arrest or cardiogenic shock

- Bood gases result availability up to 4 hours after coronary unit admission

Exclusion criteria

Exclusion Criteria:

  • Lack of patient anthropometric data (height and weight) available in the patient record
  • No information in the record regarding the data on the humidification systems used at the time of the first blood gas test upon admission to the coronary care unit.
  • Patient stabilzed in other hospital before coronary unit admission or adjustment of respiratory parameters after a blood gas test.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patient post cardiac arrest

    Other: Initiation of mechanical ventilation

  • Patient with cardiogenic shock

    Other: Initiation of mechanical ventilation

Interventions

  • OtherInitiation of mechanical ventilation

    Blood gases evaluation after initiation of mechanical ventilation

06

What researchers measure

Primary outcomes

  1. Acid-base disorder (respiratory acidosis)

    Presence of respiratory acisosis define by pH\< 7.35 and PaCO2 \> 45 mmHg

    Time frame: Up to 4 hours after admission to the coronary care unit - First blood gas sample

  2. Acid-base disorder (respiratory alcalosis)

    Presence of respiratory alcalosis define by by pH\>7.45 and PaCO2 \< 35 mmHg

    Time frame: Up to 4 hours after admission to the coronary care unit - First blood gas sample

Secondary outcomes

  1. Ventilator setting (Respiratory rate)

    Respiratory rate set by the doctor, these setting will be compared to the suggestion of the algorithm

    Time frame: Up to 4 hour after coronary unit admission - At the last ventilator setting before blood gas sample

  2. Ventilator setting (Tidal volume)

    Tidal volume set by the doctor, these setting will be compared to the suggestion of the algorithm

    Time frame: Up to 4 hour after coronary unit admission - At the last ventilator setting before blood gas sample

  3. Acid-base disorder (metabolic acidosis)

    Presence of metabolic acidosis define by HCO3 \< 20 mmol/L

    Time frame: Up to 4 hours after admission to the coronary care unit - First blood gas sample

  4. Acid-base disorder (metabolic alcalosis)

    Presence of metabolic acidosis define by HCO3 \> 28 mmol/L

    Time frame: Up to 4 hours after admission to the coronary care unit - First blood gas sample

  5. Optimal acid-base result

    Presence of optimal pH (7.35-7.45) with optimal PCO2 (35-45 mmHg)

    Time frame: Up to 4 hours after admission to the coronary care unit - First blood gas sample

  6. Mechanical ventilation duration

    Time spent with invasive mechanical ventilation aftercoronary unit admission and hospital discharge

    Time frame: Up to 90 days

  7. Vasopressor duration

    Duration of vasopressor or inotrop administration

    Time frame: Day 28

  8. Hospital length of stay

    Coronary unit admission through hospital discharge

    Time frame: Up to 90 days

  9. Mortality

    Mortality at coronary unit

    Time frame: Day 28

  10. Acute renal failure

    Rate of acute renal failure during coronary unit length of stay. Renal failure will be defined according to the usual criteria, i.e., an increase of \>27 mmol/L creatinine in 48 hours or 1.5x over the baseline

    Time frame: Up to 90 days. Coronary unit stay - admission through discharge or until death if occured

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Jun 2026 (actual). Primary completion is estimated for Jun 2027, 12 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 5, 2026: start May 2026 → Jun 2026, primary completion Sep 2026 → Jun 2027 and completion Dec 2026 → Dec 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 5, 2026
First posted
Mar 20, 2026
StartActual
Jun 9, 2026was May 2026
Primary completionEst.
Jun 2027was Sep 2026
CompletionEst.
Dec 2027was Dec 2026
Last update
Nov 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 5, 2026
Sites
Insitut universitaire de cardiologie et de pneumologie de Quebec - Universite Laval is now Recruiting
Nov 5, 2026
Start date
May 2026→Jun 9, 2026 (actual)
Nov 5, 2026
Primary completion
Sep 2026→Jun 2027
Nov 5, 2026
Study completion
Dec 2026→Dec 2027
Nov 5, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Insitut universitaire de cardiologie et de pneumologie de Quebec - Universite Laval · Québec, CanadaContact added f•••@criucpq.ulaval.ca · •••8711
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    Not yet recruiting→Recruiting
    Insitut universitaire de cardiologie et de pneumologie de Quebec - Universite Laval is now Recruiting
    Start date May 2026→Jun 9, 2026 (now actual)
    Primary completion Sep 2026→Jun 2027
    Study completion Dec 2026→Dec 2027
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Insitut universitaire de cardiologie et de pneumologie de Quebec - Universite Laval · Québec, CanadaContact added f•••@criucpq.ulaval.ca · •••8711

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07484828
Lead sponsor
Laval University
Responsible party
François Lellouche (Principal Investigator, Laval University) — Principal investigator
First posted
Mar 20, 2026
Start date
Jun 9, 2026
Primary completion
Jun 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Nov 5, 2026

Study contacts

Francois Lellouche
Contact
francois.lellouche@criucpq.ulaval.ca
1-418-656-8711 ext. 3572

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion